EVALUATION OF WHITE BLOOD CELL GROWTH FACTOR (WBCGF) USE IN METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS

被引：0
|
作者：
Hoverman, J. R. [1 ]
Sheth, S. [1 ]
Clayton, M. [1 ]
Garey, J. [1 ]
Beveridge, R. [1 ]
机构：
[1] US Oncol Network McKesson Specialty Hlth, Level Pathways Task Force 1, The Woodlands, TX USA
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：425 / 426
页数：2
相关论文
共 50 条
  • [31] Compliance with oral topotecan in patients with non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
    Eckardt, J. R.
    Ramlau, R.
    Gervais, R.
    Shepherd, F.
    O'Brien, M.
    Ciuleanu, T.
    Dharan, B.
    Wissel, P.
    Ross, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 387S - 387S
  • [32] Depression, survival, and epidermal growth factor receptor genotypes in patients with metastatic non-small cell lung cancer
    Pirl, William F.
    Traeger, Lara
    Greer, Joseph A.
    Jackson, Vicki
    Lennes, Inga T.
    Gallagher, Emily
    Sequist, Lecia
    Temel, Jennifer S.
    PALLIATIVE & SUPPORTIVE CARE, 2013, 11 (03) : 223 - 229
  • [33] EVALUATION OF EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONS IN BULGARIAN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Bichev, S.
    Marinova, D. M.
    Slavova, Y.
    Savov, A.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S16 - S16
  • [34] Optimum timing of gefitinib therapy in metastatic non-small cell lung cancer (NSCLC) patients.
    Ayllon, J
    Plazanet, V
    Guillevin, EF
    Banu, E
    Bonan, B
    Oudard, S
    Barthes, FP
    Theou, N
    Sors, H
    Andrieu, JM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 700S - 700S
  • [35] CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS OF METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS IN MEXICO
    Flores-Caballero, M. A.
    Lugo-Martinez, G.
    Rodriguez-Cid, J. R.
    Juarez-Vignon Whaley, J.
    Martinez-Herrera, J. F.
    Cruz-Zermeno, M.
    Seidman-Sorsby, A.
    Garcia-Montes, V
    Garibay-Diaz, J. C.
    Gonzalez Espinosa, I
    Hernandez-Flores, O.
    Oyervides-Juarez, V. M.
    Lopez Lopez, F.
    Gonzalez-Cisneros, P.
    Riera Sala, R.
    Alatorre-Alexander, J.
    Dorokhova, E.
    Betancur, M. A.
    Medina, S.
    Flores-Garcia, L.
    Amaya-Gutierrez, M. J.
    Rodriguez-Rosales, Y.
    VALUE IN HEALTH, 2023, 26 (12) : S238 - S238
  • [36] Non-small cell lung cancer: Evaluation of node and metastatic staging
    Brauner, M.
    Brillet, P. -Y.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2008, 64 (05) : 245 - 249
  • [37] Palliative Radiation Therapy (RT) Practice In Metastatic Non-small Cell Lung Cancer (NSCLC) Patients
    Chen, A. B.
    Chen, K.
    Weeks, J.
    Chrischilles, E.
    Malin, J.
    Schrag, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S590 - S590
  • [38] Serum metastin is not involved in metastatic potential of non-small cell lung cancer (NSCLC)
    Karapanagiotou, E. M.
    Dilana, K. D.
    Boura, P. G.
    Gratsias, I.
    Polyzos, A.
    Syrigos, K. N.
    EJC SUPPLEMENTS, 2009, 7 (02): : 519 - 519
  • [39] Current approaches in chemotherapy of advanced and metastatic non-small cell lung cancer (NSCLC)
    Reck, M
    ANTICANCER RESEARCH, 2005, 25 (3A) : 1501 - 1506
  • [40] Epidermal growth factor receptor (EGFR) mutation testingin non-small cell lung cancer (NSCLC) patients (pts).
    Sequist, L. V.
    Joshi, V. A.
    Jänne, P. A.
    Fidias, P.
    Muzikansky, A.
    Meyerson, M.
    Haber, D. A.
    Kucherlapati, R.
    Johnson, B. E.
    Lynch, T. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 408S - 408S
12345